Trial
NCT02345460
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Case Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Pancreatic Adenocarcinoma
Intervention
Irinotecan Hydrochloride
Why stopped
Competing studies
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-13